BIOS
Income statement / Annual
Last year (2022), BioPlus Acquisition Corp.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2022, BioPlus Acquisition Corp.'s net income was $5.16 M.
See BioPlus Acquisition Corp.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2022
|
FY-2021
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
FY-2013
|
FY-2012
|
FY-2011
|
| Period Ended |
12/31/2022 |
12/31/2021 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
12/31/2013 |
12/31/2012 |
12/31/2011 |
| Operating Revenue |
$0.00
|
$0.00
|
$708.90 M
|
$817.20 M
|
$935.60 M
|
$982.20 M
|
$984.10 M
|
$842.20 M
|
$662.60 M
|
$0.00
|
| Cost of Revenue |
$1.17 M |
$0.00 |
$465.90 M |
$547.90 M |
$670.00 M |
$721.30 M |
$723.00 M |
$570.40 M |
$437.70 M |
$0.00 |
| Gross Profit |
-$1.17 M |
$0.00 |
$243.00 M |
$269.30 M |
$265.60 M |
$260.90 M |
$261.10 M |
$271.80 M |
$224.90 M |
$0.00 |
| Gross Profit Ratio |
0 |
0 |
0.34 |
0.33 |
0.28 |
0.27 |
0.27 |
0.32 |
0.34 |
0 |
| Research and Development
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| General & Administrative
Expenses |
$0.00
|
$0.00
|
$47.30 M
|
$63.30 M
|
$66.00 M
|
$83.60 M
|
$319.40 M
|
$254.00 M
|
$198.50 M
|
$0.00
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$1,171.20
|
$162.43
|
$47.30 M
|
$63.30 M
|
$66.00 M
|
$83.60 M
|
$319.40 M
|
$254.00 M
|
$198.50 M
|
$0.00
|
| Other Expenses |
$1.17 M |
$0.00 |
$189.60 M |
$220.80 M |
$197.70 M |
$465.00 M |
$35.10 M |
$40.70 M |
$13.10 M |
$4.80 M |
| Operating Expenses |
$1.17 M |
$162.43 |
$236.90 M |
$284.10 M |
$263.70 M |
$548.60 M |
$354.50 M |
$294.70 M |
$211.60 M |
$4.80 M |
| Cost And Expenses |
$1.17 M |
$162.43 |
$702.80 M |
$832.00 M |
$933.70 M |
$1.27 B |
$1.08 B |
$865.10 M |
$649.30 M |
$4.80 M |
| Interest Income |
$3.17 M |
$9.49 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Interest Expense |
-$3.17 M |
$0.00 |
-$57.40 M |
-$52.10 M |
-$38.20 M |
-$37.30 M |
-$38.50 M |
$28.20 M |
$26.07 M |
$28.31 M |
| Depreciation &
Amortization |
$228,485.00
|
$236,558.00
|
$23.60 M
|
$27.73 M
|
$21.55 M
|
$22.74 M
|
-$81.10 M
|
-$16.10 M
|
$73.07 M
|
$15.88 M
|
| EBITDA |
-$1.17 M
|
$9.49
|
-$84.90 M
|
-$24.97 M
|
-$56.15 M
|
-$335.76 M
|
-$174.60 M
|
-$39.00 M
|
$86.37 M
|
$39.39 M
|
| EBITDA Ratio |
0 |
0 |
-0.12 |
-0.03 |
-0.06 |
-0.34 |
-0.18 |
-0.05 |
0.13 |
0 |
| Operating Income Ratio
|
0
|
0
|
-0.15
|
-0.06
|
-0.08
|
-0.36
|
-0.1
|
-0.03
|
0.02
|
0
|
| Total Other
Income/Expenses Net |
$3.17 M
|
$9.49
|
$57.50 M
|
-$14.70 M
|
$45.30 M
|
$33.50 M
|
-$38.50 M
|
-$28.20 M
|
-$26.10 M
|
-$28.31 M
|
| Income Before Tax |
$2.00 M |
-$152.95 |
-$51.00 M |
-$67.40 M |
-$32.40 M |
-$325.00 M |
-$132.00 M |
-$51.10 M |
-$12.80 M |
-$4.80 M |
| Income Before Tax Ratio
|
0
|
0
|
-0.07
|
-0.08
|
-0.03
|
-0.33
|
-0.13
|
-0.06
|
-0.02
|
0
|
| Income Tax Expense |
-$3.17 M |
$9.49 |
$600,000.00 |
$63.60 M |
$2.00 M |
-$21.50 M |
$11.40 M |
$2.50 M |
-$4.40 M |
$28.31 M |
| Net Income |
$5.16 M |
-$152.95 |
-$51.60 M |
-$131.00 M |
-$34.40 M |
-$303.50 M |
-$143.40 M |
-$53.60 M |
-$8.40 M |
-$33.11 M |
| Net Income Ratio |
0 |
0 |
-0.07 |
-0.16 |
-0.04 |
-0.31 |
-0.15 |
-0.06 |
-0.01 |
0 |
| EPS |
0.0086 |
-0.0222 |
-0.4 |
-1.06 |
-0.37 |
-4.42 |
-2.09 |
-0.83 |
-0.15 |
-0.6 |
| EPS Diluted |
0.0086 |
-0.0222 |
-0.4 |
-1.06 |
-0.37 |
-4.42 |
-2.09 |
-0.83 |
-0.15 |
-0.6 |
| Weighted Average Shares
Out |
$597.79 M
|
$6,875.77
|
$127.90 M
|
$123.80 M
|
$93.70 M
|
$68.70 M
|
$68.50 M
|
$64.60 M
|
$56.20 M
|
$55.20 M
|
| Weighted Average Shares
Out Diluted |
$597.79 M
|
$6,875.77
|
$127.90 M
|
$123.80 M
|
$93.70 M
|
$68.70 M
|
$68.50 M
|
$64.60 M
|
$56.20 M
|
$55.20 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
